THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Venture investing at highest since '01

Biotech leads surge; firms in region net $975.5m in quarter

By Robert Weisman
Globe Staff / April 24, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Fueled by a surge in biotechnology funding, first-quarter venture capital investing climbed to its highest level nationally since the last three months of 2001, according to the quarterly MoneyTree report set to be released today. (Full article: 653 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass